IRB Barcelona Nets $1.3M to Fuel Cancer Dx, Bioinformatics Spinoffs | GenomeWeb

NEW YORK (GenomeWeb News) – The Botin Foundation of Madrid has awarded €1 million ($1.3 million) to fund two technology spin-off initiatives at the Institute for Research in Biomedicine, Barcelona, including projects that will develop and seek to commercialize a test for colon cancer metastasis and a bioinformatics platform for simulating new drug designs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.